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Background: Glaucoma is the leading cause of irreversible visual impairment in
the world affecting 60.5 million people worldwide in 2010, which is expected to
increase to approximately 79.6 million by 2020. Therefore, glaucoma screening is
important to detect, diagnose, and treat patients at the earlier stages to prevent
disease progression and vision loss. Teleglaucoma uses stereoscopic digital
imaging to take ocular images, which are transmitted electronically to an ocular
specialist. The purpose is to synthesize literature to evaluate teleglaucoma, its
diagnostic accuracy, healthcare system benefits, and cost-effectiveness.
Methods: A systematic search was conducted to help locate published and
unpublished studies. Studies which evaluate teleglaucoma as a screening device
for glaucoma were included. A meta-analysis was conducted to provide estimates
of diagnostic accuracy, diagnostic odds ratio, and the relative percentage of
glaucoma cases detected. The improvements to healthcare service quality and cost
data were assessed.
Results: Of 11237 studies reviewed, 45 were included. Our results indicated that,
teleglaucoma is more specific and less sensitive than in-person examination. The
pooled estimates of sensitivity was 0.832 [95% CI 0.770, 0.881] and specificity was
0.790 [95% CI 0.668, 0.876]. The relative odds of a positive screen test in glaucoma
cases are 18.7 times more likely than a negative screen test in a non-glaucoma
cases. Additionally, the mean cost for every case of glaucoma detected was
$1098.67 US and of teleglaucoma per patient screened was $922.77 US.
Conclusion: Teleglaucoma can accurately discriminate between screen test
results with greater odds for positive cases. It detects more cases of glaucoma than
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in-person examination. Both patients and the healthcare systems benefit from early
detection, reduction in wait and travel times, increased specialist referral rates, and
cost savings. Teleglaucoma is an effective screening tool for glaucoma specifically
for remote and under-services communities.

Introduction
Vision impairment represents a serious public health concern since it impacts
social, mental, and physical health of an individual. Visual impairment limits
independence and activities of daily life. Those with visual impairment require
more social support systems, visual aids, and modifications to home life. They are
at a higher risk for injuries, falls, psychological conditions, and are admitted to
nursing homes earlier compared to those without a vision impairment [1].
Glaucoma is the leading cause of irreversible visual impairment in the world
affecting 60.5 million people worldwide in 2010 [2]. In developed countries, half
of glaucoma patients may not experience vision loss until the advanced stages of
the disease and this is expected to be greater in undeveloped countries [3]. Since
there is no cure for glaucoma, glaucoma can progress to blindness if left untreated.
Further, glaucoma accounts for 12% of blind persons worldwide which is
expected to increase to approximately 79.6 million in 2020 [4]. The largest impact
is expected in China and India, which accounts for 40% of all cases together [4].
The burden of the glaucoma has affected both the health care and economic
systems. In Canada, alone, vision loss costs the economy $15.8 billion per year in
which 55% is allocated to direct health care costs [5]. Sixty-five per cent of adults
with partial or full vision loss are unemployed, which translates to $4.06 billion
annually of lost earnings [5]. The direct costs of glaucoma is estimated in the
United States to be $623 for mild, $1915 for moderate, and $2511 for severe forms
of glaucoma and similarly in Europe the costs are J455 per person each year for
mild glaucoma and J969 per person each year for severe glaucoma [4]. Varma et
al. reported as glaucoma progresses to each stage, there is an J86 increase in
treatments costs in European.
Glaucoma screening is important to detect, diagnose, and treat patients at the
earlier stages. Screening and diagnostic tools are significant to prevent glaucoma
from progressing to advanced stages and maintaining health vision. In addition,
glaucoma prevention will minimize future healthcare costs. Screening improves
efficiency of the health care system by increasing the number of patients accessing
ophthalmic services and it reduces the number of false-positive referrals to
ophthalmologists [6].
The standard of care for glaucoma screening is routine optometrist visits every
2–3 years and any suspect glaucoma patient will be referred to an ophthalmologist
for additional diagnostic testing [5]. Those of older ages are at a greater risk of
glaucoma and thus ophthalmologists recommend routine optometrist visits every
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2 to 4 years for adults between 40 to 64 years and every 1 to 2 years when aged 65
and older [7]. Patients regularly seen by ophthalmologist for other ocular
conditions may also be referred for glaucoma diagnostic testing if signs appear.
In-patient care for glaucoma (passive ‘‘in-person screening’’) is performed at
specialized clinics and includes detailed history, slit lamp examination, visual field
testing, and fundus photography performed by the optical technician followed by
consultation with the ophthalmologist [8].
Teleglaucoma is a relatively new screening and diagnostic tool for targeting
remote or under-serviced communities. It uses stereoscopic digital imaging to
take ocular images which are transmitted electronically to an ocular specialist. The
ocular specialist will then assess the images, identify risk factors and diagnose for
glaucoma. If necessary the ocular specialist will refer identified glaucoma cases for
medical consultations or to ophthalmologists for follow-up treatment. Unlike
other teleophthalmology tools, teleglaucoma requires more sophisticated
diagnostic tests. The main tests are optic nerve photographs, Optical Coherence
Tomography (OCT), Intraocular Pressure (IOP) measurements, central corneal
thickness (CCT) measurements, and visual field tests [9]. The combination of
examinations and equipment required can vary based on organizational resources,
target goals and populations. However, the more diagnostic tools used during
screening for glaucoma the greater the accuracy and effectiveness of the screening
process. The equipment required for teleglaucoma are the ophthalmic examination equipment, cameras, and computer imaging software. The A full list of the
standard equipment and components of teleglaucoma can be found in Table 1
[9].
The advantages reported in the literature include convenience, decreased travel
time to medical clinics, increased access to specialized care for glaucoma, and
decreased patient costs [10, 11] The benefits are mainly seen in remote or underserviced communities such as Aboriginal communities and rural or remote areas
where there is limited ocular specialists. Arora et al. reported improved access
time (time from patient being referred to the date visit is booked) with
teleglaucoma versus standard in-person examinations: 45 days for teleglaucoma
versus in-person exam which had 88 days [12]. Teleglaucoma had reduced cycle
time (time from registration until patient leaves clinic) of 78 minutes versus inperson exam of 115 minutes [12]. The pioneer teleglaucoma study conducted in
Finland reported reduced absence from work by 50% with teleglaucoma versus inperson examination, and in addition reduced traveling (97%), costs (92%), and
time (92%) [11].
The literature suggests teleglaucoma has comparable diagnostic accuracy.
Teleglaucoma technology demonstrated moderate agreement in its ability to
diagnose glaucoma (Kappa statistic 0.55% (0.48, 0.62)) [13]. When disc damage
had Vertical Cup Disc Ratio (VCDR) greater than 0.7 the Frequency Doubling
Technology (FDT) had a substantial agreement with ability to diagnose glaucoma
(kappa statistic 0.84) [13]. In addition, a study conducted in rural India compared
the ability of teleglaucoma to detect glaucoma compared to standard in-clinic
examination and found that there was good agreement in detecting glaucoma
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Table 1. Standardized teleglaucoma equipment.
Components

Requirements

Human Resources

Staff: graders, Ophthalmic technicians, nurses, optometrist, physicians, glaucoma specialists/ophthalmologists

Information Technology

Secure Diagnostic Imaging (SDI) system
Videoconferencing equipment
Computer systems and software
ISDN installation

Screening Equipment

Retinal camera
Tonometer
Devices to measure central corneal thickness
Frequency Doubling Technology (FDT) or Humphrey Visual Field test
Optical Coherence Tomography
Slit lamp
Gonioscope
Retinal camera
Tonometer
Devices to measure central corneal thickness

Examinations

Medical & family history
Visual acuity
IOP
CCT
Pupil equal and reactive to light (PERL) or relative afferent pupillary defect (RAPD)
Slit lamp
Gonioscopy
Visual field
Fundus photographs
OCT
Ancillary tests

doi:10.1371/journal.pone.0113779.t001

[14]. For glaucoma the kappa scores were 0.61 with standard screening versus 0.59
for teleglaucoma [14]. In comparison to the in-person slit lamp examination, the
positive predictive value was 77.5% for positive teleglaucoma diagnosis and had a
negative predictive value of 82.2% for negative teleglaucoma diagnosis [13].
However, a cohort study conducted by the University of Alberta found 24% of
teleglaucoma photographs were deemed unreadable from media opacities, patient
cooperation, and unsatisfactory photographic techniques [13].
In this study, a systematic review and meta-analysis was conducted on
teleglaucoma screening for patients with glaucoma to evaluate the following: the
effectiveness of teleglaucoma as a screening device, its diagnostic accuracy, its
diagnostic odds ratio, and its cost-effectiveness in comparison to in-person
examination. Section 2 will explain the methods, section 3 provides the detailed
analysis, and section 4 concludes with a discussion and implications for future
research.
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Methods
Search Strategy
A search methodology was used to assist in locating both published and
unpublished studies. Research databases and conference meeting abstracts were
searched for articles published from 1999 to current, and included MEDLINE
(OVID and PubMed), Cochrane Library (Wiley), BIOSIS (Thomson-Reuters),
CINAHL (EBSCO), Web of Science (Thomson-Reuters), and EMBASE (OVID).
The grey literature was explored by searching Dissertations and Theses
(ProQuest), the Canadian Health Research Collection (Ebrary), as well as the
annual meeting abstracts of the European Society of Ophthalmology, Canadian
Society of Ophthalmology (CSO), Association for Research in Vision and
Ophthalmology (ARVO), and American Academy of Ophthalmology (AAO). The
Conference Proceedings Citation Index was also included as part of the Web of
Science search. Hand searches of ARVO’s Investigative Ophthalmology & Visual
Science journal and Canadian Journal of Ophthalmology associated with CSO were
performed. The search strategies employed database specific subject headings and
keywords for glaucoma, tele-screening, detection, and their synonyms. Each
strategy was structured to accommodate for database and platform specific
terminology, and syntax. Supplementary File S1 contains the complete search
strategies used for the various databases (Table S1). Alerts were set up for each
database to receive publication notifications for new related articles.

Inclusion and exclusion criteria
Articles included were from any country, all in English, published from 1999 to
current, and were research articles. The articles included study population that are
adults in the general population or populations at risk of glaucoma. The study
population included those with or without glaucoma. Articles on teleglaucoma
intervention for glaucoma screening were included, both in-comparison to inperson screening and analyzing teleglaucoma on its own. Outcome measures of
teleglaucoma articles selected contained efficiency measures, specificity, sensitivity, and its ability to detect glaucoma, as well as patient benefits and cost data.
Economic evaluations such as cost-effectiveness analysis and studies with costing
data were also included.
The exclusion criteria was articles published prior to 1999 since teleglaucoma is
fairly new and to be consistent with the teleglaucoma screening procedure, year
1999 was selected as a cut-off year. Additionally, non-research articles such as
methodology papers, editorials, review articles, commentaries, and letters were
excluded. Articles on diagnosis or prognosis, genetic screening, and teleophthalmology for ocular conditions other than glaucoma were eliminated.
A total of 11237 articles were retrieved by searching various databases and an
additional 526 were retrieved from hand searching and grey literature search
which were then imported into EPPI 4.0 reference manager. Based on the
inclusion and exclusion criteria, two reviewers independently reviewed all articles.
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After removing duplicate articles, 8157 articles were included for screening.
Articles were screened by title, abstract, and full text in level 1, 2, and 3 screening
respectively. After each level of screening, kappa statistics was calculated to
measure reviewer’s agreement. Additionally, if consensus was not reached by the
two reviewers’ then a third reviewer intervened to solve disagreements on article
eligibility. The agreement between the two reviewers was excellent (kappa 50.86).
The PRISMA diagram demonstrating the selection process is displayed in Figure 1
(Table S3).

Quality Assessment Strategy
Articles were assessed using the Grading of Recommendations, Assessment,
Development, and Evaluation (GRADE) guidelines for publication bias, risk of
bias, imprecision, inconsistency, and indirectness [15–20]. Articles were graded as
either low, moderate, or high quality of evidence. The results indicated that 17
articles were high quality, 13 were moderate quality, and 15 articles were graded as
low quality of evidence. Despite the quality of evidence, all articles were included
in the analysis.

Data Extraction Strategy
Qualitative and quantitative data necessary for analysis was obtained from each
article. Information on study location, design, effect measures (sensitivity and
specificity), percentage of glaucoma diagnosed, service times, image quality, visual
acuities, ophthalmic characteristics, and costs were collected. One reviewer
extracted data using an excel template. Authors were emailed to obtain missing
relevant information. All databases were updated with new information from
respective authors. Additional current costing data was provided by ophthalmic
equipment vendors INNOVA, Topcon, and Ocular Health Network. Costs were
converted to 2014 US dollars [21]. This research study has no financial
relationships, investments, or sponsorship related to the cited commercial
vendors.

Data Analysis
Data was synthesized and analyzed using STATA 13. When studies reported
estimates as range or p-value or multiple estimates, mean and standard deviation
(SD) were derived. Hierarchical logistic regression was used to determine the
pooled estimates of sensitivity and specificity of teleglaucoma and in-person
examination. A graphical representation of the summary estimates was presented
in a Hierarchical Summary Receiver Operating Characteristic (HSROC) curve
with 95% confidence intervals and 95% prediction regions.
The positive/negative likelihood ratios (LR+/LR2) were calculated using
bivariate models to generate estimates of the likelihood of a positive/negative test
in a glaucoma/non-glaucoma patient. From this result the diagnostic odds ratio
(DOR) was calculated to determine the relative diagnostic effectiveness of
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Figure 1. PRISMA diagram.
doi:10.1371/journal.pone.0113779.g001
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Table 2. Baseline characteristics of included studies – demographics.
Author (Year)

Location

Study Design

Sample Size

Population

Tuulonen et al. (1999) [11]

Finland

PC

70

Glaucoma patients

Eikelboom et al. (1999) [31]

Australia

PC

27

Glaucoma patients

Li et al. (1999) [35]

USA

PC

32

Diabetic adults

Yogesan et al. (1999) [36]

Australia

PC

27

Glaucoma clinic patients/suspected of glaucoma

Michelson et al. (2000) [37]

Germany

PC

10

Glaucoma-diagnosed patients

Yogesan et al. (2000) [38]

Indonesia

PC

14

Ophthalmic Clinic patients

Yogesan et al. (2000) [39]

Australia

PC

43

Ophthalmic Clinic patients

Gonzalez et al. (2001) [40]

Spain

PC

139

Ophthalmic Clinic patients

Sebastian et al. (2001) [41]

Spain

CS

74

Glaucoma suspects

Wegner et al. (2003) [42]

Germany

PC

1733

Not stated

Labiris et al. (2003) [43]

Greece

PC

1205

Glaucoma-diagnosed patients

Fansi et al. (2003) [44]

Canada

PC

33

Glaucoma suspects or diagnosed

Jin et al. (2003) [45]

Canada

CEA

339

Diabetic aboriginals

Chen et al. (2004) [46]

Taiwan

PC

113

Residents of area aged .40 years

de Mul et al. (2004) [47]

Netherlands

PC

1729

Optometrist patients at-risk for glaucoma

Ianchulev et al. (2005) [32]

USA

PC

33

Glaucoma suspects or diagnosed

Paul et al. (2006) [48]

India

PC

348

Rural residents at risk for glaucoma

Kumar et al. (2006) [33]

Australia

PC

107

Patients of the Eye Clinic

Kumar et al. (2007) [49]

New Zealand

PC

201

General eye examination clinic Patients

Khouri et al. (2007) [50]

Not Stated

CS

30

Glaucoma-diagnosed patients

Pasquale et al. (2007) [51]

USA

PC

350

Diabetic

Khouri et al. (2008) [52]

USA

PC

28

Glaucoma-diagnosed patients

deBont et al. (2008) [53]

USA

PC

1729

Optometrist patients at-risk for glaucoma

Sogbesan et al. (2010) [54]

Canada

CEA/PC

–

Optometrist patients at-risk for glaucoma

Anton-Lopez et al. (2011) [55]

Spain

CS

1599

At-risk for glaucoma

Khurana et al. (2011) [56]

India

CS

91698

Ophthalmic Clinic patients

Staffieri et al. (2011) [57]

Tasmania

PC

133

High risk (First degree relatives of diagnosed POAG)

Swierk et al. (2011) [58]

Germany

EE

–

Ophthalmic Clinic patients

Amin et al. (2012) [59]

Canada

PC

72

Glaucoma suspects or early stages of OAG

Shahid et al. (2012) [6]

USA

CS

341

Urban soup kitchen/homeless

Kassam et al. (2012) [9]

Canada

PC

257

At-risk for glaucoma or early-stage glaucoma

Gupta et al. (2013) [14]

India

PC

247

Ophthalmic Clinic patients

Damji et al. (2013) [60]

Canada

PC

71

Ophthalmic Clinic patients

Kiage et al. (2013) [13]

rural Africa

PC

309

Diabetic adults

Verma et al. (2013) [61]

Canada

RC

247

Optometrist-referred glaucoma suspects or early OAG

Ahmed et al. (2013) [62]

USA

RC

643

Diabetic and hypertensive

Arora et al. (2014) [12]

Alberta

PC

71

Glaucoma clinic patients/suspected of glaucoma

Legend: CS 5 Cross-Sectional Study, PC 5 Prospective Cohort Study, CEA 5 Cost-effectiveness Analysis, RCS 5 Retrospective Cohort Study, EE 5
Economic Evaluation, – 5 Not Stated.
doi:10.1371/journal.pone.0113779.t002
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Table 3. Baseline characteristics of included studies – intervention.
Author (Year)

Teleglaucoma Equipment

Comparator

Tuulonen et al. (1999) [11]

Canon CR5-45NM non-mydriatic fundus camera, slit-lamp, Panasonic
video camera, HF II perimeter

In-person examination

Eikelboom et al. (1999) [31]

Nidek Nm-100 Handheld fundus camera

Teleglaucoma only
Image Quality of Teleglaucoma

Li et al. (1999) [35]

Non-mydriatic retinal camera. Digital images

Yogesan et al. (1999) [36]

Portable fundus camera, Nidek NM100

Teleglaucoma only

Michelson et al. (2000) [37]

Self-tonometry portable device called Ocuton, PalPilot, IOP curve

Teleglaucoma only

Yogesan et al. (2000) [38]

Handheld fundus camera (NM100)

Teleglaucoma only

Yogesan et al. (2000) [39]

DIO digital indirect ophthalmoscope, handheld fundus camera Nidek
NM100, stereo fundus camera (Nidek 3D-x)

Teleglaucoma only

Gonzalez et al. (2001) [40]

Non-mydriatic fundus camera (canon CR6-45M)

In-person examination

Sebastian et al. (2001) [41]

C-20-5 FDT, Humphrey-Zeiss, & Topcon optic nerve head photographs

Teleglaucoma only

Wegner et al. (2003) [42]

Goldman applanation tonometer and mobile HRT

Teleglaucoma only

Labiris et al. (2003) [43]

Slit lamp, Octapus perimeter visual field, fundus camera, Optotype, air
tonometer

In-person examination

Fansi et al. (2003) [44]

–

Healthy vs Glaucoma eyes

Jin et al. (2003) [45]

Tonometry

In-person examination

Chen et al. (2004) [46]

Digital 35-degree colour fundus images, non-mydriatic digital fundus
camera (CR6-45, Canon)

In-person examination

de Mul et al. (2004) [47]

Nerve fibre analyser, GDx

In-person examination

Ianchulev et al. (2005) [32]

Peristat: self-test

In-person examination

Paul et al. (2006) [48]

–

Teleglaucoma only

Kumar et al. (2006) [33]

I-care tonometry

Teleglaucoma only

Kumar et al. (2007) [49]

–

In-person examination

Khouri et al. (2007) [50]

Digital stereo fundus camera - Nidek 3-Dx

Image Quality of Teleglaucoma

Pasquale et al. (2007) [51]

Topcon TRC NW-5S non-mydriatic retinal camera (Paramus) interfaced
to a standard color video camera (Sony 970-MD)

Teleglaucoma only

Khouri et al. (2008) [52]

Non-mydriatic 45-deg camera, Canon Japan. DICOM image format

Image Quality of Teleglaucoma

deBont et al. (2008) [53]

Nerve fibre analyser, GDx

Image Quality of Teleglaucoma

Sogbesan (2010) [54]

–

In-person examination

Anton-Lopez et al. (2011) [55] HRT, nerve-fibre analyzer (GDX-VCC), I-Care (rebound tonometry)

In-person examination
Teleglaucoma only

Khurana et al. (2011) [56]

–

Staffieri et al. (2011) [57]

–

Teleglaucoma only

Swierk et al. (2011) [58]

–

In-person examination

Amin et al. (2012) [59]

Slit lamp, IOP, CCT, visual field, anterior and stereo posterior segment
photos and OCT

In-person examination

Shahid et al. (2012) [6]

8.2 megapixel non-mydriatic retinal camera

Teleglaucoma only

Kassam et al. (2012) [9]

Remote service - slit lamp, fundus photographs,

In-person examination

Gupta et al. (2013) [14]

Fundus Camera (Portcam II)

In-person examination

Damji et al. (2013) [60]

–

In-person examination

Kiage et al. (2013) [13]

Topcon 777

In-person examination

Verma et al. (2013) [61]

–

In-person examination

Ahmed et al. (2013) [62]

Topcon TRC non-mydriatic retinal camera, Tonopen

Teleglaucoma only

Arora et al. (2014) [12]

–

In-person examination

doi:10.1371/journal.pone.0113779.t003
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teleglaucoma. DOR is the ratio of the odds of a positive screen test in a glaucoma
case relative to the odds of a negative screen test in a non-glaucoma case [22].
Due to the variability of study effectiveness measures, not one article had a
complete set of data. Missing data was treated as statistically missing values and
not included in the analysis. Only articles with complete data were included in
each analysis. Publication bias was assessed using funnel plots.

Results
A total of 45 studies were included in this meta-analysis. Table 2 and Table 3
display the baseline characteristics of each study. Studies were conducted in
fourteen different countries with representation in each continent. All articles
were published between 1999 and 2014. The cumulated individuals of all studies
were 101,512 participants. All studies were observational studies, as there were no
randomized controlled trials conducted. Three studies contained economic
evaluations or cost-effectiveness analysis. Of the 45 studies, 16 compared
teleglaucoma to in-person examination. The other 29 studies analyzed
teleglaucoma without comparison or was an evaluation of different teleglaucoma
equipment. There was minimal variation in study populations; they included
either glaucoma patients or patients who were at risk of glaucoma (based on
diabetes status, family history of glaucoma, age, or ethnicity). Table 4 displays
additional study details on demographics and study methods (glaucoma
definition, pupil dilation, and number of field tests examined). Although there
was some variation, less than 10% of studies reported these details. The main
outcome measures were specificity and sensitivity (Table 5). Other included
outcome measures (percentage of glaucoma diagnosed, referral rate, and
proportion of images with poor quality) are displayed in table 5.
Costing data was given by nine studies and the quality of analysis of costing is
displayed in table 6. Teleglaucoma costs vary by the capacity of the service and the
type and amount of equipment. The current vendor estimate shows that the total
costs for standard glaucoma equipment range from 89,703.53 to 123,164.55 US
dollars (Table 6) [23, 24]. Additionally, to transfer images and patient test results
securely to ophthalmologists electronically a service exists costing $62.13 US/
month [21, 25]. This service allows teleglaucoma technicians and ophthalmologists to login electronically to attach, send, view and assess retinal images and
patient test results.
Costing data from the literature shows the cost per detected case of glaucoma
ranged from $13.03–2020.96 US after conversion to US dollars and adjusted for
inflation to 2014 costs (Table 7) [26]. The mean cost is $1098.67 US for every case
of glaucoma detected (n53) (Table 7). The mean cost of teleglaucoma per patient
screened was $922.77 US (n52) (Table 7).
Another necessary costing aspect is the ophthalmologist fee for glaucoma
consultation. The ophthalmologist may be compensated for each teleglaucoma
referral or time spent on teleophthalmology consultations. Compensation varies
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Table 4. Additional Details on Baseline Characteristics of Included Studies.
Study Population
Ethnicity

Glaucoma definition

# Field
Dilated pupil tests

Eikelboom et al. (1999)
[31]

–

–

Yes

–

Yogesan et al. (1999)
[36]

–

–

Yes

–

Yogesan et al. (2000)
[38]

–

–

Yes

–

Yogesan et al. (2000)
[39]

–

–

Yes

–

Ianchulev et al. (2005)
[32]

15% White, 9% African
American, 76% Hispanic

–

No

–

Chen et al. (2004) [46]

100% Asian

‘‘The diagnosis of glaucoma was made according to the
–
anatomical findings from the patient’s optic nerve disc, and
functional visual field examination by frequency-doubling
perimetry (FDP). Intraocular pressure (IOP) was also evaluated.
An elevated IOP was defined as over 17 mmHg (1 mmH5133 Pa).
Severe glaucoma was defined as an optic cup: disc ratio over 0.7
with an FDP defect or elevated IOP. Mild glaucoma was defined
as an optic cup: disc ratio between 0.7 and 0.5, or disc
asymmetry of over 20%, with an FDP defect or elevated IOP.’’

Author (Year)

–

Kumar et al. (2006) [33] 96% Caucasian, 4% Asian IOP of 21 mmHg was threshold for suspected glaucoma

–

–

Paul et al. (2006) [48]

–

–

–

In accordance with glaucoma screening protocol of Lions Eye
Institute: Vertical cup disc ratio (VCDR) .0.5, IOP .21 mmHg,
abnormal visual field related to glaucoma, and or disk
asymmetry .0.2.

Yes

–

100% Indian

Kumar et al. (2007) [49] –

Pasquale et al. (2007)
[51]

16% African American
(of glaucoma suspects)
14% African American
(Of non-glaucoma
suspects)

Staffieri et al. (2011) [57] –

‘‘VFs were considered glaucomatous if the pattern deviation plot
–
showed a nasal step, nasal depression, arcuate defect,
paracentral loss that respected the horizontal meridian, or
temporal wedge defects based on previously published criteria…
Patients were designated as ‘‘no glaucoma’’ if the CDR was ‘‘,0.6 in
both eyes and CDR asymmetry was ,0.1 in the absence of reliable
glaucomatous VFs. Patients were designated as having ‘‘glaucomasuspicious optic discs’’ if the CDR was ’’.0.6 in either eye or CDR
asymmetry was .0.1 with or without reliable glaucomatous VFs.
Patients with more subtle optic nerve changes were labeled as
having glaucoma-suspicious optic discs if VFs were available and
reliable and showed change consistent with glaucomatous loss.’’

Three

‘‘Subjects were classified as having definite glaucoma on the
Yes
basis of characteristic optic nerve head changes (cup: disc ratio
[CDR] outside the 97.5 percentile for the normal population or rim
width less than 0.1 CDR at the superior and inferior poles of the disc)
and definite visual field defect consistent with glaucoma. Individuals
with stereoscopic disc photos consistent with structural damage but
in whom field testing was unreliable or unobtainable were classified
as glaucoma suspect.’’

–

Khurana et al. (2011)
[56]

100% Indian

–

–

–

Anton-Lopez et al.
(2011) [55]

–

‘‘2/3 Criteria were considered suspects and referred for glaucoma
consultation: (1) global Moorefield’s Regression Analysis
borderline or outside normal limits, (2) Nerve Fibre Index .30,
and tonometry .21 mmHg.’’

–

–

Shahid et al. (2012) [6]

78% African American,
10% Caucasian, 6.7%
Hispanic, 4.8% Other

–

Yes

One
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Table 4. Cont.
Author (Year)

Study Population
Ethnicity

# Field
Dilated pupil tests

Kiage et al. (2013) [13]

100% African

Category 1 diagnosis (structural and functional evidence): 2 out
of 3 of the following: VCDR $0.7, focal glaucoma disc changes,
VCDR asymmetry ($0.2). Category 2 diagnosis (structural
evidence with unproved field loss): 2 out of 3 of the following:
VCDR $0.8, focal glaucoma disc changes, VCDR asymmetry
$0.3. Category 3 diagnosis (optic disc not clearly seen): 1 of
the following visual acuity ,3/60 and IOP. 21 mmHg or visual
acuity ,3/60 and evidence of glaucoma surgery or medical
records confirming glaucoma morbidity. Glaucoma suspect: one
of the following IOP $23 mmHg, 1/3 of the glaucomatous optic
neuropathy listed in category 2, glaucoma visual field defect only.

Yes

Three

Gupta et al. (2013) [14]

100% Indian

Glaucoma diagnosis based on disc findings VCDR of $0.7 or
focal neuroretinal rim defect.

Yes

–

Glaucoma definition

doi:10.1371/journal.pone.0113779.t004

Table 5. Study relevant outcome measures.
Author (Year)

Specificity (%)

Sensitivity (%)

Percentage Glaucoma
diagnosed

Percentage Referral
Rate

Percentage of Image
of Poor Quality

Li et al. (1999) [35]

–

–

–

–

18.8
–

Yogesan et al. (1999) [36]

84.5

82.5

–

–

Eikelboom et al. (1999) [31]

71.5

67

–

–

–

Yogesan et al. (2000) [39]

87

100

–

–

–

Gonzalez et al.(2001) [40]

–

–

7.9

–

13

Sebastian et al. (2001) [41]

–

–

2.7

–

4

Wegner et al. (2003) [42]

–

–

–

9.4

de Mul et al. (2004) [47]

58

82

4.6

11

–

Ianchulev et al. (2005) [32]

95.5

81.5

–

–

–

Kumar et al. (2006) [33]

98.8

38.1

–

–

–

Kumar et al. (2007) [49]

93.6

91.1

–

–

–

Pasquale et al. (2007) [51]

96

59

–

–

–

deBont et al. (2008) [53]

–

–

–

11

11

Staffieri et al. (2011) [57]

–

–

5

–

–

Anton-Lopez et al. (2011) [55] –

–

1.9

7.7

–

12.5

–

Khurana et al. (2011) [56]

–

–

1.06

Shahid et al. (2012) [6]

–

–

32

Ahmed et al. (2013) [62]

–

–

–

19.4

5

Gupta et al. (2013) [14]

81.82

72.1

–

–

–

Kiage et al. (2013) [13]

89.6

41.3

14

–

24

Verma et al. (2013) [61]

–

–

31

31

Arora et al. (2014) [12]

–

–

44

–

–

–

doi:10.1371/journal.pone.0113779.t005
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Table 6. Quality of analysis for costing.
Author (Year)

Object

Tuulonen et al. (1999) [11]

Fixed Costs

Costs ($)

Currency

Fundus camera (1 unit)

200

FIM

ISDN installation (3 units)

6.5

FIM

Server computer (2 units for 5 years)

50

FIM

Software application (2 units for 5yrs)

50

FIM

Video slit-lamp (1 unit)

40

FIM

Write off 10 years (3%)

40.62

FIM

Use of teleophthalmology equipment

24.372

FIM

Video conference equipment

84

FIM

Write-off 5 years

18.342

FIM

Automated perimetry – Humphrey

132

FIM

Write off 10 years (3%)

15.474

FIM

Service and updating

5

FIM

Line costs per month

3.672

FIM

Premise

1.608

FIM

Utilities

1.608

FIM

Other fixed costs

Other costs

7.133

FIM

Yogesan et al. (2000) [38]

Satellite phone

30000

EUR

Mobile phone

3250

EUR

Jin et al. (2003) [45]

Total expenditure capital

160260

CAN

Operating costs per 1 year

348665

CAN

Projected 2005 Costs

385226

CAN

Operating costs amortized over 5 years

32052

CAN

Operating costs amortized over 5 years per diabetic case 1231

CAN

Professional and Lab Fees

291

CAN

Costs per patient

1231

CAN

Travel costs

805

CAN

Escort travel expenses

340

CAN

Chen et al. (2004) [46]

Costs per detected case

10

US

Ianchulev et al. (2005) [32]

Costs per targeted glaucoma screening

60

US

Costs per detected case

1000

US

Sogbesan (2010) [54]

Patient savings

2527

CAN

Anton-Lopez et al. (2011) [55]

Incremental Costs

24150

EUR

Costs per detected case

1420

EUR

Primary Care visit

15

EUR

General Ophthalmic Visit

18

EUR

Ophthalmic Visit with tests

52

EUR

Glaucoma Consultation

26

EUR

Swierk et al. (2011) [58]

Ahmed et al. (2013) [62]

Medical Care

291.21

EUR

Accommodation costs

280

EUR

Costs per patient

288.72

EUR

Equipment costs (digital retinal camera, Tonopen and
computer)

46000

US
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Table 6. Cont.
Author (Year)

Object

Costs ($)

Currency

Vendor Estimates (2014) [23, 24]

OCT

48,000–49,000

CAN

Slit Lamp

7,420–19,990

CAN

Slit lamp mounted

1,400–2,400

CAN

Non-contact

8,995

CAN

Retinal Camera

27,900–27, 995

CAN

Visual Field Analyser

16,340–32,420

CAN

TOTAL RANGE:

89,703.53–123,164.55

US

70/Month

CAN

Tonometer

Ocular Health Network (2014) [25] Imaging Transfer Service
doi:10.1371/journal.pone.0113779.t006

by states and/or provinces, government legislation, and available private grants. In
the United States, Medicare and Medicaid provide several reimbursement
programs for physicians delivering telemedicine consultations [27, 28]. In
Ontario, Canada, the compensation for the fee-for service model, is $16.00 CAN
per ophthalmic referral [29]. The physician liable for teleglaucoma consultations
must be a licensed ophthalmologist in both the area of the service and the patient.
Physicians must hold liability coverage appropriate to state/provincial laws. In
Canada, the Canadian Medical Protective Association provides ophthalmologists
with liability coverage for teleophthalmology [30].
Ten studies had complete data necessary to conduct the analysis for
teleglaucoma diagnostic accuracy. The summary estimate for sensitivity was 0.833
[95% CI 0.77, 0.88] and specificity was 0.79 [95% CI 0.668, 0.875] for glaucoma
screening using optic nerve examinations (Figure 2). The summary estimates
indicate that teleglaucoma correctly detects 83.3% of glaucoma cases and correctly
classifies 79% of those without glaucoma as glaucoma-negative. Figure 3 displays
each study estimate and the summary estimate with its associated confidence
intervals and the generated HSROC curve. The distribution of the studies in the
Table 7. Teleglaucoma estimated 2014 unit costs.
Author (Year)

Cost per detected case ($US)
Cost per patient ($US) (Adjusted for Inflation Rate
(Adjusted for inflation to 2014 costs) Inflation Rate (%) inflation to 2014 costs)
(%)

Jin et al. (2003) [45]

–

–

1434.63

25.49

Chen et al. (2004) [46]

13.03

30.32

–

–

Ianchulev et al. (2005) [32]

1262.02

26.2

–

–

Anton-Lopez et al. (2011) [55] 2020.96

5.89

–

–

–

410.91

5.89

Swierk et al. (2011) [58]

–

Mean costs

1098.67

922.77

doi:10.1371/journal.pone.0113779.t007
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Figure 2. Hierarchical logistic regression results.
doi:10.1371/journal.pone.0113779.g002
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Figure 3. Hierarchical Summary Receiver Operating Characteristic (HSROC) plot.
doi:10.1371/journal.pone.0113779.g003

plot demonstrates the variability of both specificity and sensitivity amongst
studies. Six studies fall outside of the 95% confidence interval of the summary
estimate. The 95% prediction region is the estimate of future observations. The
results demonstrate a fairly wide prediction region for both true predictions of
specificity and sensitivity, with greater variability expected for specificity.
The study populations used to assess diagnostic accuracy were those at-risk of
glaucoma (based on diabetes status, family history, age, ethnicity, etc.),
optometrist and ophthalmic clinic patients, and patients who were glaucoma
suspects (Table 1). One study reported its study population as glaucoma patients
only (Table 1) and contrary, this study had one of the lower reported scores for
diagnostic accuracy: specificity was 71.5% and sensitivity was 67% (Table 5) [31].
The diagnostic tools of the included studies varied slightly (Table 8). Eight out
of the ten studies analyzed for sensitivity and specificity used at minimum optic
nerve examinations as part of the screening process (Table 8). The other two
studies reported using IOP or visual field defects as the methods to detect
glaucoma suspects (Table 8). For these studies which did not include fundus
photographs, the sensitivity and specificity were 81.5% and 95.5% respectively for
glaucoma screening using only visual field and 38.1% and 98.8% respectively for
glaucoma screening using IOP and Orbscan Topography (Table 5) [32, 33].
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Table 8. Study ophthalmic examinations.
Author (Year)

Examination tests

Li et al. (1999) [35]

Optic disc photographs, VCDR

Yogesan et al. (1999) [36]

VCDR

Eikelboom et al. (1999) [31]

VCDR

Yogesan et al. (2000) [39]

Fundus images, H/VCDR, radial rim measurements

Gonzalez et al.(2001) [40]

Fundus images

Sebastian et al. (2001) [41]

Visual acuity, IOP, FDT, optic nerve head photographs

Wegner et al. (2003) [42]

HRT, IOP, OCT

de Mul et al. (2004) [47]

IOP, nerve fibre indicators

Ianchulev et al. (2005) [32]

HVF, visual acuity

Kumar et al. (2006) [33]

IOP, CCT, ACT

Kumar et al. (2007) [49]

IOP, FDT, VCDR, disc asymmetry, visual field, fundus photographs

Pasquale et al. (2007) [51]

IOP, CDR, Humphrey visual field, comprehensive eye examination

deBont et al. (2008) [53]

Nerve fiber indicators, fundus photographs, IOP

Staffieri et al. (2011) [57]

Visual acuity, refractive status, visual field testing, IOP, CCT, stereoscopic optic disc photographs

Anton-Lopez et al. (2011) [55]

IOP, HRT, nerve fibre indicators

Khurana et al. (2011) [56]

–

Shahid et al. (2012) [6]

IOP, optic nerve head appearance and asymmetry, nerve fibre layer dropouts

Ahmed et al. (2013) [62]

Fundus images, CDR, IOP

Gupta et al. (2013) [14]

Fundus photographs

Kiage et al. (2013) [13]

Slit lamp examination, focal glaucoma damage, VCDR, IOP, FDT, fundus images, visual fields

Verma et al. (2013) [61]

Stereoscopic optic nerve images, visual fields, ancillary tests, IOP, OCT, and HRT

Arora et al. (2014) [12]

OCT, HRT, stereo-nerve photographs, FDT, HVF, OCT, IOP

Legend: VCDR 5 vertical cup-to-disc ratio, HCDR 5 horizontal cup-to-disc ratio, IOP 5 intraocular pressure, FDT 5 frequency doubling technology, CCT 5
central corneal thickness, HRT 5 Heidelberg Retinal Tomography, CDR 5cup-to-disc ratio, HVF 5 Humphrey Visual Field, ACT 5 anterior chamber depth,
POAG 5 primary open angle glaucoma, OAG 5 open angle glaucoma.
doi:10.1371/journal.pone.0113779.t008

Three studies reported sensitivity and specificity of in-person examination. The
weighted mean of sensitivity was 74.9¡27.6% (n53) and specificity was
88.8¡10.3% (n53) for in-person examination. The summary estimates indicate
that in-person examination correctly detects 74.9% of glaucoma cases and
correctly classifies 88.8% of those without glaucoma as glaucoma-negative.
The positive likelihood ratio was 3.97 [95% CI: 2.3–6.7] while the negative
likelihood ratio was 0.21 [95% CI: 0.14–0.32] (Figure 2). This demonstrates that
the likelihood of a positive screen test in a glaucoma case is greater than the
likelihood of a negative screen test in a non-glaucoma case. In addition, the
positive likelihood ratio is greater than one and thus the positive screen test is
associated with glaucoma. Since the negative likelihood ratio is less than one, the
negative screen test is associated with the absence of disease [22]. The effectiveness
of the diagnostic accuracy of teleglaucoma was given by the DOR, which was 18.7
[95% CI: 7.9–44.4] (Figure 2). The relative odds of a positive screen test in
glaucoma cases are 18.7 times more likely than a negative screen test in a non-
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glaucoma case. Since the DOR was greater than one the test is discriminating
between true positives and true negatives correctly [22].
There was insufficient data to conduct hierarchical logistic regression on the
percentage of glaucoma diagnosed. Three of the 45 studies reported percentage of
glaucoma diagnosed in both teleglaucoma and in-person examination necessary
for analysis. The mean percentage of glaucoma diagnosed was 13.4% for
teleglaucoma and 7.8% for in-person examination which suggests that
teleglaucoma is capable of detecting more cases of glaucoma.
Other effectiveness measures of teleglaucoma were analyzed such as variables of
healthcare service quality. The mean percentage of patients referred to specialist
for consultation was 12.5¡7.8% (n56). The mean percentage of images that were
of poor quality was 10.4¡6.7% (n57). It took a mean time of 75.6¡87.7 seconds
(n54) to process the teleglaucoma images. Timing associated with teleglaucoma
service is another measure of quality. The mean time for screening was
8.8¡5.1 minutes (n53). The time reported for ophthalmologist to make
diagnosis was 34 minutes (n51). The mean reporting time was 7.6¡2.6 minutes
(n56). Teleglaucoma gave a reduction for patient travel time of 61.23 hours
(n51). Teleglaucoma had a mean access time (time from patient being referred to
the date visit is booked) of 59.7¡9.9 minutes (n54) in comparison to
73.7¡29.8 minutes (n54) for in-person examination. The mean cycle time (time
from registration until patient leaves clinic) for teleglaucoma was 81.7¡6 minutes
(n52), which was less than that of in-person examination, 116¡2.5 minutes
(n52). The mean proportion of patient satisfaction with teleglaucoma was
47.3¡8.8% (n52) while only 42% (n51) were satisfied with in-person
examination.

Discussion
Telemedicine has demonstrated good use for offering glaucoma services to people
of remote areas. Teleglaucoma is beneficial to remote areas as the physician is not
required to see patients in person, which reduces wait times and shortens the
length of ophthalmic consultations. Teleglaucoma avoids long distance travel and
time wasted on commute. The results of the pooled estimates for diagnostic
accuracy have shown teleglaucoma to be more sensitive and less specific than inperson examinations. Teleglaucoma is advantageous at detecting true positive
cases of glaucoma, but has a higher rate of false positives in comparison to inperson examination. With very high DOR estimates, it is suggested that
teleglaucoma can accurately discriminate screen tests. Teleglaucoma has
demonstrated capability to detect glaucoma cases that may not have been detected
during in-person examination. Glaucoma progresses without patient awareness
and it is usually detected at the advanced stages. Thus teleglaucoma serves as a
tool for early detection of glaucoma. If caught earlier and with treatment,
glaucoma can be effectively managed and can result in the preservation of vision.
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Telemedicine for glaucoma can have several combinations of examinations and
measurements used for glaucoma screening. Examination of fundus photographs
are commonly used for teleglaucoma screening. Four of the ten studies analyzed
used only fundus examinations while another four studies included IOP, CCT,
visual field loss, and visual acuity, in addition to fundus photograph examinations
(Table 8). Two studies did not use fundus photograph examination but rather
visual acuity, IOP, CCT, and ACT (Table 8). However, this is based on studies
who explicitly stated the terms for ophthalmic examination. Some studies
reported ‘‘comprehensive eye examinations’’ were performed, but did not
explicitly state which examinations were performed, thus assumptions cannot be
made. The use of different tests for glaucoma screening can potentially bias the
results as the more diagnostic tools used during screening results in a greater
probability of correct diagnosis naturally. However, the results did not show any
significant differences in accuracy with studies which reported using multiple
diagnostic tools. Interestingly, the specificity and sensitivity values reported
ranged independent of the number and the type of examination used for
teleglaucoma (Table 4 and Table 8).
The combinations of examinations are dependent on financial and resource
limitations of the hosting organization and can vary from small programs to very
large programs. It is dependent on the target goals and target populations of the
organization. However, the standard examinations recommended for glaucoma
screening are those that can evaluate visual field defects, IOP, and the biological
structure and function of the optic nerve. These include HRT, OCT, optic disc
photography, RNFL photography, as well as FDT, tonometry, and perimetry [34].
There were limitations within the study. Insufficient data reported was a major
limitation of the meta-analysis, although authors were contacted for additional
information. Nevertheless, the key goal was to systematically review the literature
on tele-glaucoma and in-person screening and perform the meta-analysis. With
small samples sizes there was not enough power to show statistical or clinical
significance. Different comparators were reported by studies and to ensure
internal validity, only studies with exact comparators were analyzed together. This
was one of the reasons for reduced sample sizes for the analysis. However, our
analysis does provide information on diagnostic accuracy of teleglaucoma, its
capability to detect glaucoma, and to detect negative and positive cases correctly.
It demonstrates teleglaucoma has the potential as a screening device to detect a
greater amount of cases than in-person examination. Since teleglaucoma is an
active screening, it suggests glaucoma cases are detected at earlier stages. However
the significance of this difference is limited by the number of comparative studies.
The majority of the studies were non-comparative which, in addition, limits the
significance of the relative effectiveness to in-person examination.
Teleglaucoma has been evaluated in many different ways: diagnostic accuracy,
cost reduction, technological capabilities (image quality, image transmission
speed, etc.), reduction of patient and health care provider time, and convenience.
Thus many studies focus on only part of the effectiveness. As a result, there is
insufficient data when summarizing all of the studies together. This has proven
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the need for more research literature on the diagnostic accuracy of teleglaucoma
and its ability to detect glaucoma in comparison to in-person examination. There
is a need for research on the follow-up of detected cases and long-term effects of
teleglaucoma. In addition, better quality of evidence through randomized
controlled trials is recommended. There are implications for cost-effectiveness
analyses. Although, costing data suggests cost savings for patients’ time and travel
with teleglaucoma, a thorough costing of current health care expenditure is
required to determine its overall cost-effectiveness from the scope of the
healthcare system.
Teleglaucoma is beneficial to offering services in underserviced regions and
rural areas. It considerably reduces patient access times and cycle times. The time
required for service is shorter than in-person examination and physician
commitments are reduced. As a result teleglaucoma saves costs to patients and
costs to the health care system as a whole.
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